Articles by Jon S. Kauffman, PhD - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Jon S. Kauffman, PhD

Jon S. Kauffman, PhD

Manager

Jon S. Kauffman, PhD, is the manager of method development and validation at Lancaster Laboratories, Inc.

Articles
Identification and Risk-Assessment of Extractables and Leachables
February 1, 2006

Extractable and leachable issues should be resolved early in the drug manufacturing process. Open communication is imperative for a successful study.

Trends in Impurity Analyis: Determination of Extractables, Leachables, Residual Solvents, and Unknowns by Mass Spectrometry
August 1, 2003

Advances in mass spectrometry have made it a valuable tool for use in the quality-control laboratory.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
32%
Breakthrough designations
8%
Protecting the supply chain
40%
Expedited reviews of drug submissions
8%
More stakeholder involvement
12%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
FindPharma Custom Search
Click here